Abstract
One hundred large bowel carcinomas operated on between 1978 and 1982 were studied immunohistochemically with regard to expression of HLA-DR antigens. Three sections from each tumour were investigated by a semiquantitative scoring system, and a mean score for each patient established. Based on this scoring system, the tumours were divided into three groups: 0; 0.1-1.0; and > 1.0. All patients were followed until death (n = 68) or until June 1, 1992, and all cancer-specific deaths (n = 56) have been recorded. Analysis of survival in the whole patient group showed significant difference between the three levels of tumour HLA-DR expression (P = 0.006); patients who had tumours with strong HLA-DR expression showing the best survival. In a stratified analysis after Dukes' stages there was still a significant difference (P > 0.001) between the three levels of HLA-DR staining intensity. After a multiple regression analysis (Cox) with correction for different variables, the HLA-DR expression maintained its significance as a risk factor. To our knowledge this is the first time a relationship between intensity of tumour DR expression and survival has been shown in large bowel carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersen, S., Rognum, T., Lund, E. et al. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 68, 80–85 (1993). https://doi.org/10.1038/bjc.1993.290
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.290
This article is cited by
-
MHC heterogeneity and response of metastases to immunotherapy
Cancer and Metastasis Reviews (2021)
-
Characterising the prognostic potential of HLA-DR during colorectal cancer development
Cancer Immunology, Immunotherapy (2020)
-
Expression of HLA-DR genes in gliomas: correlation with clinicopathological features and prognosis
Chinese Neurosurgical Journal (2017)
-
Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers
Oncogene (2012)
-
MHC class II expression in pancreatic tumors: a link to intratumoral inflammation
Virchows Archiv (2012)